Physician profile
Samiha Alam
NPI 1457736761
$655.52
in general payments reported to CMS, 2019-2025
15 companies · $38.06 in 2025
The $38.06 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $79.79 · 2021: $81.84 · 2022: $231 · 2023: $85.93 · 2025: $38.06.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $123.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gm Pharmaceuticals, INC. | $192.02 | 2022 | |
| Sanofi Pasteur INC. | $61.44 | 2023 | |
| Ironshore Pharmaceuticals INC. | $59.29 | 2019-2020 | |
| Cranial Technologies, INC | $56.70 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $53.35 | 2019-2023 | M-M-R II, Vaxelis, Gardasil 9 |
| Vertical Pharmaceuticals, LLC | $44.05 | 2019-2020 | |
| Pfizer INC. | $34.95 | 2019 | |
| Sobi, INC | $28.56 | 2019-2020 | |
| Tris Pharma INC | $23.01 | 2025 | Onyda Xr |
| Genentech USA, INC. | $22.61 | 2020 | |
| Glaxosmithkline, LLC. | $21.36 | 2021 | |
| Supernus Pharmaceuticals, INC. | $16.22 | 2021 | |
| Collegium Pharmaceutical, INC. | $15.05 | 2025 | Jornay Pm |
| Takeda Pharmaceuticals U.S.A., INC. | $13.89 | 2020 | |
| Adlon Therapeutics L.P. | $13.02 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samiha Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.